Leuprolide U.S. label context · version 1
This page preserves this version's wording and source pins. Open the current profile →
What does the U.S. product label say?
Leuprolide acetate injection · Read September 15, 2026 · Preserved label summary 1
Which population and use does the label cover?
The cited injection label covers palliative treatment of advanced prostate cancer. Other leuprolide formulations and gynecologic or pediatric indications require their own product records. Label: indications and usage ↗
Which safety limits matter?
The label describes initial testosterone increases and possible worsening of cancer symptoms, including urinary obstruction or spinal cord compression. It also addresses severe skin reactions, hypersensitivity, hyperglycemia or diabetes, cardiovascular events reported with GnRH agonists, QT prolongation and potential fetal harm. Label: contraindications, warnings, precautions ↗
Label edition and source pins
U.S. product labeling hosted by the National Library of Medicine. This account concerns this product and label edition; other formulations and jurisdictions require their own records.
Leuprolide acetate kit · SPL version 10 · published 2026-07-06
Label ZIP SHA-256: 86f3963f5e8c460c7214ef2ac8e45182d3919a279b0fa097bf03eb2c5632471d. Extracted XML SHA-256: 62478327ea5fa12911efbec7eef842d246d0987362191dbd644223838558fcdb.